CMBA
PRVL

C.M. Bidwell & Associates’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

C.M. Bidwell & Associates’s Portfolio PRVL Stock Details PRVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,965
Closed -$29K – 531
2020
Q2 		$29K Buy
+1,965
New +$29K 0.03% 280